Table 2 Crude and adjusted hazard ratios of Parkinson’s disease for various cancers.

Overall cancer (n = 3165)

11.52

14.09

−2.57 (−3.82 to −1.32)

0.82 (0.74–0.91)

<0.001^a

0.62 (0.56–0.68)

<0.001^a

0.63 (0.57–0.69)

<0.001^a

Gastric cancer (n = 689)

2.70

2.95

−0.25 (−0.82 to 0.32)

0.91 (0.75–1.12)

0.387

0.68 (0.56–0.84)

<0.001^a

0.69 (0.56–0.85)

<0.001^a

Thyroid cancer (n = 160)

0.57

0.69

−0.11 (−0.39 to 0.16)

0.76 (0.49–1.17)

0.216

0.58 (0.38–0.90)

0.015^a

0.60 (0.39–0.93)

0.022^a

Colorectal cancer (n = 637)

1.98

2.81

−0.83 (−1.37 to −0.28)

0.71 (0.56–0.89)

0.004^a

0.55 (0.44–0.70)

<0.001^a

0.56 (0.44–0.70)

<0.001^a

Lung cancer (n = 756)

2.71

3.24

−0.53 (−1.12 to 0.06)

0.86 (0.71–1.06)

0.153

0.69 (0.57–0.85)

<0.001^a

0.71 (0.58–0.87)

0.001^a

Hepatic cancer (n = 364)

1.26

1.57

−0.31 (−0.72 to 0.10)

0.83 (0.62–1.11)

0.197

0.64 (0.47–0.86)

0.003^a

0.64 (0.48–0.86)

0.003^a

Bladder cancer (n = 194)

0.69

0.83

−0.14 (−0.44 to 0.16)

0.86 (0.58–1.28)

0.462

0.71 (0.48–1.06)

0.091

0.71 (0.48–1.06)

0.091

Pancreatic cancer (n = 201)

0.45

0.91

−0.46 (−0.77 to −0.16)

0.50 (0.31–0.80)

0.004^a

0.36 (0.22–0.58)

0.001^a

0.37 (0.23–0.60)

0.001^a

Gallbladder and biliary duct cancer (n = 201)

0.88

0.82

0.05 (−0.25 to 0.36)

1.07 (0.75–1.52)

0.730

0.85 (0.59–1.23)

0.389

0.87 (0.61–1.26)

0.461

Kidney cancer (n = 92)

0.52

0.35

0.17 (−0.03 to 0.38)

1.41 (0.87–2.28)

0.161

1.14 (0.70–1.85)

0.606

1.14 (0.70–1.86)

0.597

Hematological malignancy (n = 175)

0.55

0.76

−0.22 (−0.50 to 0.06)

0.70 (0.45–1.08)

0.109

0.56 (0.36–0.88)

0.011^a

0.56 (0.36–0.87)

0.010^a